Role of nitric oxide in inflammation-mediated neurodegeneration

Annals of the New York Academy of Sciences

Volumn 962, Issue , 2002, Pages 318-331

  Liu, Bin ^a   Gao, Hui Ming ^a   Wang, Jiz Yuh ^a   Jeohn, Gwang Ho ^a   Cooper, Cynthia L ^a   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Inflammation; Lipopolysaccharide; Naloxone; Neurodegeneration; Neuroprotection; Nitric oxide; Opioids; Superoxide

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE ANTAGONIST; S [2 (1 IMINOETHYLAMINO)ETHYL]HOMOCYSTEINE; SUPEROXIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL ACTIVATION; CELL CULTURE; CELL KINETICS; CONFERENCE PAPER; CYTOKINE RELEASE; ENCEPHALITIS; ENZYME INDUCTION; GLIA CELL; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE;

RODENTIA;

EID: 0036272473     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04077.x     Document Type: Conference Paper

References (101)

1. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
2. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
3. Oxidative damage and tyrosine nitration from peroxynitrite
4. Microglia: A sensor for pathological events in the CNS
5. The role of microglia and astrocytes in CNS immune surveillance and immunopathology
6. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
7. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
8. Multiple sclerosis: Immune system molecule expression in the central nervous system
9. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease
10. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
11. Microglia as mediators of inflammatory and degenerative diseases
12. Microglia and the immune pathology of Alzheimer disease
13. Cytotoxicity of microglia
14. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
15. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrastriatal dopaminergic system
16. Interferon-gamma plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus
17. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide
18. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats
19. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
20. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
21. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia
22. Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat
23. Time dependency of the action of nitric oxide in lipopolysaccharide-interferon-gamma-induced neuronal cell death in murine primary neuron-glia co-cultures
24. Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS
25. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway
26. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
27. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors
28. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo
29. Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide
30. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat
31. Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal
32. Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins
33. Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS
34. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells
35. 15N]nitrate in biological fluids
36. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation
37. Glia: The not so innocent bystanders
38. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: In vitro and in vivo studies
39. Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide
40. Nitric oxide synthase induction in astroglial cell cultures: Effect on heat shock protein 70 synthesis and oxidant/antioxidant balance
41. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells
42. Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D3
43. BCL-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells
44. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons
45. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures
46. Nitric oxide induces oxidative stress and apoptosis in neuronal cells
47. The indolocarbazole Go6976 protects neurons from lipopolysaccharide/interferon-gamma-induced cytotoxicity in murine neuron/glia co-cultures
48. Post-transcriptional inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by Go6976 in murine microglia
49. p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures
50. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures
51. Cytokine-mediated neuronal apoptosis
52. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
53. Nitric oxide: Role in neurotoxicity
54. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation
55. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency
56. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage
57. Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells
58. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
59. Nitric oxide: An endogenous modulator of leukocyte adhesion
60. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
61. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes
62. Extracellular signal-regulated kinase and p38 subgroups of mitogen- activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures
63. Gö6976 inhibits LPS-induced TNFa release by suppressing p38 MAP kinase activation
64. Pharmacology of dynorphin
65. Cardiac Opioids
66. Molecular biology of the opioid receptors: Structures, functions and distributions
67. Effects of opioids on the immune system
68. Opioids and their complicated receptor complexes
69. 5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures
70. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures
71. Studies in the (+)-morphinin series-5. Synthesis and biological properties of (+)-naloxone
72. A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activation
73. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: A study by electron paramagnetic resonance spectroscopy
74. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism
75. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock
76. Endogenous opioids and their antagonist in endotoxic shock
77. Naloxone therapy in shock: The controversy continues
78. Promising pharmacological agents in the management of acute spinal cord injury
79. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period
80. Reversal of induced ischemic neurologic deficit in gerbil by the opiate antagonist naloxone
81. A double blind trial of naloxone in the treatment of stroke
82. Pharmacological strategies in CNS trauma
83. Naloxone reversal of ischemic arrhythmia is stereospecific and suggesting role of endogenous opioid peptides in ischemic heart disease
84. Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion
85. Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matchedcontrols
86. Effects of naloxone in senile dementia: A double-blind trial
87. Alzheimer's disease: Clinical features, pathogenesis, and treatment
88. Low- and high-dose naloxone in dementia of the Alzheimer type
89. Molecular consequences of activated microglia in the brain: Overactivation induces apoptosis
90. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage
91. Naltrexone and Alzheimer's disease
92. Multicenter trial of naloxone in Alzheimer's disease
93. High-dose naloxone in older normal subjects: Implications for Alzheimer's disease
94. Adjunctive therapies for sepsis and septic shock
95. Anti-inflammatory therapies in sepsis and septic shock
96. Novel agents in the therapy of endotoxic shock
97. Naloxone inhibits superoxide release from human neutrophils
98. Inhibition by naloxone of neutrophil superoxide release: A potentially useful antiinflammatory effect
99. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes
100. Opioids and cardioprotection